Jasper Therapeutics

JSPR50

$19.83arrow_drop_up9.07%$1.64

JSPR50

$19.83

arrow_drop_up9.07%$1.64

Performance History

Key Stats
Open	$18.53
Prev. Close	$18.18
EPS	-5.10
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	18.05	20.32
52 Week Range	4.00	31.01

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-5.10

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Jasper Therapeutics (JSPR)

Jasper Therapeutics, Inc. (JSPR) is a biotechnology company focused on developing innovative curative therapies for hematological conditions and cancer. The company utilizes a platform technology called Hematopoietic Stem Cell (HSC) Gene Therapy to engineer and manufacture targeted gene therapies. These therapies have the potential to treat a range of diseases, including sickle cell disease, beta-thalassemia, and leukemia.

JSPR stock has shown a promising price history since its initial public offering. The stock has steadily increased in value over time, reflecting investor confidence in the company's potential for success. As of the latest available data, the stock is trading at a higher price than its IPO price, indicating positive market reception.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Ronald A. Martell
Headquarters: Redwood City
Employees: 35
Exchange: NASDAQ

Keep an eye on Jasper Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Jasper Therapeutics's (JSPR) price per share?

The current price per share for Jasper Therapeutics (JSPR) is $19.83. The stock has seen a price change of $1.65 recently, indicating a 9.08% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Jasper Therapeutics (JSPR)?

For Jasper Therapeutics (JSPR), the 52-week high is $31.01, which is 56.38% from the current price. The 52-week low is $4, the current price is 395.75% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Jasper Therapeutics (JSPR) a growth stock?

Jasper Therapeutics (JSPR) has shown an average price growth of -1.93% over the past three years. It has received a score of 99 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Jasper Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Jasper Therapeutics (JSPR) stock price performance year to date (YTD)?

As of the latest data, Jasper Therapeutics (JSPR) has a year-to-date price change of 191.36%. Over the past month, the stock has experienced a price change of -13.67%. Over the last three months, the change has been -5.93%. Over the past six months, the figure is -16.75%.

help

Is Jasper Therapeutics (JSPR) a profitable company?

Jasper Therapeutics (JSPR) has a net income of -$64.46M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$68.86M. Furthermore, the EBITDA is -$67.01M.

help

What is the market capitalization of Jasper Therapeutics (JSPR)?

Jasper Therapeutics (JSPR) has a market capitalization of $277.03M. The average daily trading volume is 19.69, indicating the stock's liquidity and investor engagement.